{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:07:30Z","timestamp":1761491250168,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jpba.2021.114279","type":"journal-article","created":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T05:21:54Z","timestamp":1627104114000},"page":"114279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Characterization of eight unknown impurities and analysis of their source in xinfujunsu and injection by liquid chromatography coupled with ion trap\/time-of-flight mass spectrometry"],"prefix":"10.1016","volume":"204","author":[{"given":"Jian","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaixian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuxian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinqi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liya","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpba.2021.114279_bib0005","first-page":"54","article-title":"The research progress of actinomycin","volume":"32","author":"Sun","year":"2011","journal-title":"J. Capital Normal Univ."},{"year":"2006","series-title":"DNA Binding Characteristics and Inhibition of Transcription in Xitro of Novel Actinomycin D Analogs","author":"Li","key":"10.1016\/j.jpba.2021.114279_bib0010"},{"issue":"1","key":"10.1016\/j.jpba.2021.114279_bib0015","article-title":"Progress on biosynthesis of actinomycins","author":"Yuan","year":"2014","journal-title":"Amino Acids Biotic Res."},{"key":"10.1016\/j.jpba.2021.114279_bib0020","series-title":"National Drug Standards","first-page":"D5","author":"China Pharmacopoeia Committee","year":"2002"},{"key":"10.1016\/j.jpba.2021.114279_bib0025","first-page":"1","article-title":"International Council on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Q3B (R2)","year":"2006","journal-title":"Impur. New Drug Prod."},{"issue":"2","key":"10.1016\/j.jpba.2021.114279_bib0030","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jpba.2008.02.002","article-title":"Development of a liquid chromatography method for the analysis of josamycin","volume":"48","author":"Daidone","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2021.114279_bib0035","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jpba.2015.01.002","article-title":"Characterization of a novel process-related impurity in commercial bendazac lysine eye drops by LC\u2013ESI-QTOF\/MS\/MS and NMR","volume":"107","author":"Zhu","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2021.114279_bib0040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jpba.2017.03.032","article-title":"Separation and characterization of unknown impurities and isomers in flomoxef sodium by LC-IT-TOF MS and study of their negative-ion fragmentation regularities","volume":"140","author":"Xu","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"10","key":"10.1016\/j.jpba.2021.114279_bib0045","first-page":"1211","article-title":"Research on fragmentation patterns of four kinds of tetracyclines by electrospray ionization mass spectrometry","author":"Wang","year":"2018","journal-title":"Chin. J. Antibiot."},{"key":"10.1016\/j.jpba.2021.114279_bib0050","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jpba.2018.08.055","article-title":"Development of a novel HPLC method for the determination of the impurities in desonide cream and characterization of its impurities by 2D LC-IT-TOF MS","volume":"161","author":"Wang","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"8","key":"10.1016\/j.jpba.2021.114279_bib0055","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/jms.1190300808","article-title":"Fragmentation mechanisms of protonated actinomycins and their use in structural determination of unknown analogues","volume":"30","author":"Thomas","year":"1995","journal-title":"J. Mass Spectrom."},{"issue":"3","key":"10.1016\/j.jpba.2021.114279_bib0060","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/jms.3329","article-title":"MALDI-TOF mass spectrometry, an efficient technique for in situ detection and characterization of actinomycins","volume":"49","author":"Vater","year":"2014","journal-title":"J. Mass Spectrom."},{"issue":"2","key":"10.1016\/j.jpba.2021.114279_bib0065","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s13361-013-0774-y","article-title":"Structural characterization of actinomycin D using multiple ion isolation and electron induced dissociation","volume":"25","author":"Wills","year":"2014","journal-title":"J. Am. Soc. Mass Spectrom."},{"issue":"10","key":"10.1016\/j.jpba.2021.114279_bib0070","first-page":"763","article-title":"Structural characterization of actinomycins by electrospray ionization mass spectrometry","volume":"35","author":"Xie","year":"2010","journal-title":"Chin. J. Antibiot."},{"issue":"1\u201312","key":"10.1016\/j.jpba.2021.114279_bib0075","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/bms.1200160113","article-title":"Collisional activation decomposition of actinomycins using tandem mass spectrometry","volume":"16","author":"Roboz","year":"1988","journal-title":"Biomed. Environ. Mass Spectrom."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708521003903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708521003903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:17:47Z","timestamp":1760001467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708521003903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":15,"alternative-id":["S0731708521003903"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2021.114279","relation":{},"ISSN":["0731-7085"],"issn-type":[{"type":"print","value":"0731-7085"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of eight unknown impurities and analysis of their source in xinfujunsu and injection by liquid chromatography coupled with ion trap\/time-of-flight mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2021.114279","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114279"}}